Practice

Investigations

Regulatory investigations; allegations of fraud, bribery, and corruption; sanctions and money laundering; whistle-blower complaints; dawn raids — multinationals and their executives face these and other threats to their businesses and reputations.

Representative experience

Acting on behalf of BTA Bank, Kazakhstan's largest bank, in asset recovery litigation concerning US$6bn, the largest such case in the UK in 2013.

Advising a Fortune 200 company regarding an investigation by the DOJ and SEC into allegations that it paid bribes to secure a contract in China and similar allegations elsewhere.

Defending a pharma company on a substantial U.S. federal criminal investigation in connection with the promotion, marketing, and sale of one of its drugs.

Undertaking an internal investigation of Eletrobras, the largest electric company in Brazil, of allegations related to the Petrobras “Lava Jato” scandal.

Acting for Air Canada in the European Commission's air cargo cartel investigation and related private U.S. and UK litigation.

Investigating management responsibility for the delays to the A380, Airbus’ flagship twin-deck airliner.

We represented a private European bank regarding a Financial Services Authority (FSA) investigation into the adequacy of its anti-corruption control.

We advised a client in connection with an investigation by the UK Serious Fraud Office (SFO) into suspected overseas corruption.

We advised a multinational financial institution regarding a City of London Police investigation into alleged foreign corrupt business practices.

We advised a European paper mill producer regarding strategy and legal action in an internal fraud investigation in China.

We successfully represented one of the world's largest, most recognizable companies when they were barred from contracting with the U.S. government.

We conducted internal reviews of payments for a Fortune 500 pharmaceutical company

Our team advised one of the world's largest insurers in connection with an inquiry by the U.S. Committee on Oversight and Government Reform.

Published Works

The Legal 500: Bribery & Corruption Comparative Guide The In-House Lawyer

This country-specific Q&A provides an overview to bribery and corruption law in Singapore.

Quick view Full view

Hogan Lovells Publications

False Claims Act - Taking a bite of the customs duties apple?

In a decision that highlights the overlap of international trade obligations and False Claims Act (FCA) jurisprudence, a federal judge recently dismissed an FCA suit because the...

Quick view Full view

Global bribery and corruption webcast

Members of our Global Bribery and Corruption Task Force brings you a 75 minute interactive webcast which will examine trends and provide an update on topics covered in our Global bribery...

Quick view Full view

Hogan Lovells Publications

Legal and Financial Risk Newsletter – May 2018

Legal and Financial Risk newsletter on legal developments impacting corporates and financial institutions. The May 2018 edition includes articles on recent court decisions and case reports.

Quick view Full view

Hogan Lovells Publications

Health care program penalties rise with Bipartisan Budget Act of 2018

Buried within a two-year budget agreement, among hundreds of pages of federal spending legislation, are key changes to several federal health care fraud statutes. The Bipartisan Budget Act...

Quick view Full view

Hogan Lovells Publications

Delusions of adequacy: The belated tale of adequate procedures Investigations, White Collar and Fraud Alert

It's been almost seven years since the UK Bribery Act (the Act) came into force. The Act's reach is extra-territorial but on the Act's home soil, on 21 February 2018, we saw the first...

Quick view Full view
Loading data